Law students with addiction and mental health issues may be afraid to report the problems because they think that doing so would jeopardize their chances of being admitted to the bar or getting a good job after graduating, according to new study, which was conducted by a law professor, a dean of law students, and the programming director of a nonprofit focused on lawyers' mental health.
Indiana lawmakers have yet to gather for the 2016 legislative session, but already the multibillion-dollar pharmaceutical industry has clashed with influential law enforcement organizations over a proposed law that would require a prescription to buy a common cold medicine also used to make methamphetamine.
Republican Sens. Randy Head of Logansport and Jim Merritt of Indianapolis said pharmacists should have the authority to approve or disapprove sales for medicines containing pseudoephedrine, which is a decongestant used to treat colds and allergies. A rival measure backed by Indiana prosecutors and GOP House Speaker Brian Bosma would require a prescription for such medicines.
The Indiana Court of Appeals upheld a man’s convictions for making and delivering methamphetamine, but the judges did not agree that the 32-year sentence imposed by the trial court was appropriate.
Prosecutors urged Indiana legislators Wednesday to ban over-the-counter sales of a common cold medicine used to make methamphetamines and stiffen sentences for convicted drug dealers.
Even though two Indianapolis police officers did not follow the department’s general order on towing and impounding vehicles after a traffic stop, the Indiana Court of Appeals upheld a man’s drug convictions.
The top Republican in the Indiana House on Tuesday endorsed tightening state law to require a doctor's prescription for cold and allergy medications that can be used to make methamphetamine.
The Indiana Supreme Court ruled the admission of a detective’s statement regarding a controlled drug buy should not have been admitted because it resolved the issue of the defendant’s guilt, but that admission into evidence was a harmless error.
The Supreme Court of the United States will not reinstate a $250,000 award to the father of a suspected marijuana user in Maryland who was killed by police in a middle-of the-night raid.
A man who is accused of firing a handgun in front of the Birch Bayh Federal Courthouse in Indianapolis has been charged with firearm and drug offenses.
Two men who challenged their criminal charges for possessing chemical compound XLR11 had their charges dismissed by the Indiana Supreme Court Wednesday, but not because the statutes relating to the drug are unconstitutional as they had argued.
A man convicted of dealing cocaine failed to persuade the Indiana Court of Appeals to reverse due to what he claimed was an erroneous jury instruction.
Indiana Attorney General Greg Zoeller and 37 other attorneys general are urging the Senate to pass the Comprehensive Addiction and Recovery Act of 2015.
The Indiana Court of Appeals was split in a decision Wednesday regarding whether a man on trial for a drug charge should have been allowed to depose two witnesses prior to trial. The judges didn’t agree as to which caselaw is controlling in the matter.
A man’s conviction in Whitley County for dealing in methamphetamine by manufacturing was upheld by the Court of Appeals Wednesday. There is evidence that the man knowingly or intentionally aided an acquaintance in making methamphetamine in the home the defendant shared with his girlfriend.
A trial court violated the prohibition against double jeopardy by convicting a man in a bench trial of three felony cocaine possession counts, the Indiana Court of Appeals ruled in tossing out two of the convictions.
A Minnesota woman accused of violating probation says she should be able to use marijuana for religious reasons because she belongs to a pot-smoking church based in Indiana.
An Indianapolis man who got a second bite at the apple could not convince the Indiana Court of Appeals his traffic stop lasted too long.
Biotech drugmaker Amgen will pay $71 million to settle an investigation into illegal marketing of its drugs Aranesp and Enbrel, ending an investigation by 48 states and Washington, D.C.
Eli Lilly and Co. isn’t liable for withdrawal symptoms including so-called brain zaps experienced by a woman after she quit the antidepressant Cymbalta, a federal jury said.